Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 36,032Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Bendeka And Trenda

02 5Bendeka and Trenda

03 3Treakisym

04 2Treakisym/Symbenda

05 3Treanda

06 1Treanda And Bendeka

07 1Treanda and Bendeka

PharmaCompass

01

Brand Name : Bendeka and Trenda

Bendamustine Hydrochloride

arrow
Antibody Engineering
Not Confirmed

Brand Name : Bendeka and Trenda

arrow
Antibody Engineering
Not Confirmed

Bendamustine Hydrochloride

Main Therapeutic Indication : Oncology

Currency : USD

2019 Revenue in Millions : 496

2018 Revenue in Millions : 642

Growth (%) : -23

blank

02

Brand Name : Treakisym/Symbenda

Bendamustine

arrow
Antibody Engineering
Not Confirmed

Brand Name : Treakisym/Symbenda

arrow
Antibody Engineering
Not Confirmed

Bendamustine

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 68

2019 Revenue in Millions : 71

Growth (%) : -4

blank

03

Brand Name : Bendeka and Trenda

Bendamustine Hydrochloride

arrow
Antibody Engineering
Not Confirmed

Brand Name : Bendeka and Trenda

arrow
Antibody Engineering
Not Confirmed

Bendamustine Hydrochloride

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 415

2019 Revenue in Millions : 496

Growth (%) : -16

blank

04

Brand Name : Bendeka and Trenda

Bendamustine Hydrochloride

arrow
Antibody Engineering
Not Confirmed

Brand Name : Bendeka and Trenda

arrow
Antibody Engineering
Not Confirmed

Bendamustine Hydrochloride

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 385

2020 Revenue in Millions : 415

Growth (%) : -7

blank

05

Brand Name : Treakisym/Symbenda

Bendamustine

arrow
Antibody Engineering
Not Confirmed

Brand Name : Treakisym/Symbenda

arrow
Antibody Engineering
Not Confirmed

Bendamustine

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 44

2020 Revenue in Millions : 66

Growth (%) : -28

blank

06

Brand Name : Bendeka and Trenda

Bendamustine Hydrochloride

arrow
Antibody Engineering
Not Confirmed

Brand Name : Bendeka and Trenda

arrow
Antibody Engineering
Not Confirmed

Bendamustine Hydrochloride

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 316

2021 Revenue in Millions : 385

Growth (%) : -18

blank

07

Brand Name : Bendeka and Trenda

Bendamustine Hydrochloride

arrow
Antibody Engineering
Not Confirmed

Brand Name : Bendeka and Trenda

arrow
Antibody Engineering
Not Confirmed

Bendamustine Hydrochloride

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 241

2022 Revenue in Millions : 316

Growth (%) : -24

blank

08

Brand Name : Treanda

Bendamustine Hydrochloride

arrow
Antibody Engineering
Not Confirmed

09

Brand Name : Treakisym

Bendamustine Hydrochloride

arrow
Antibody Engineering
Not Confirmed

10

Brand Name : Treakisym

Bendamustine Hydrochloride

arrow
Antibody Engineering
Not Confirmed

Brand Name : Treakisym

arrow
Antibody Engineering
Not Confirmed

Bendamustine Hydrochloride

Main Therapeutic Indication : Oncology

Currency : USD

2018 Revenue in Millions : 66

2017 Revenue in Millions : 59

Growth (%) : 12%

blank